Q3 2025 Holdings
Filed 2025-11-10 | 24 holdings | $373.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $188.8M | 12,480,000 | 50.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $47.0M | 326,400 | 12.6% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $14.4M | 1,011,839 | 3.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $12.9M | 151,833 | 3.4% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $11.6M | 121,000 | 3.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $11.4M | 15,500 | 3.1% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $9.1M | 400,000 | 2.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $8.6M | 345,381 | 2.3% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $8.4M | 715,000 | 2.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $7.6M | 104,262 | 2.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $5.4M | 133,827 | 1.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $5.2M | 92,592 | 1.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $5.1M | 250,838 | 1.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $4.9M | 100,000 | 1.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $4.9M | 125,000 | 1.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.9M | 74,000 | 1.3% |
| Uniqure NV(QURE) | SHS | N90064101 | $4.4M | 75,000 | 1.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $4.3M | 316,312 | 1.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $4.0M | 437,237 | 1.1% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $3.7M | 2,981,396 | 1.0% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $3.5M | 135,182 | 0.9% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $1.3M | 100,000 | 0.3% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $1.2M | 349,323 | 0.3% |
| Geron Corp(GERN) | COM | 374163103 | $1.2M | 845,000 | 0.3% |